Clinical Trial Update: Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (COPD) has been completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: COPD, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-11-29